The results, which come on the heels of the FDA’s approval of J&J’s esketamine nasal spray Spravato as a monotherapy for ...

By Dr. Jaisingh Rajput  For individuals grappling with alcohol dependence, the path to sobriety is both a personal and ...

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on study results, an analyst ...

A new study shows that cannabidiol (CBD) can reduce the craving for alcohol in people suffering from alcoholism. CBD is a ...

Background: GABAergic anticonvulsants have been recommended for the treatment of alcohol dependence and the prevention of relapse. Several studies have demonstrated topiramate's efficacy in ...

Life Sciences (ATAI) announced topline results from Beckley Psytech’s Phase 2a open-label study of BPL-003 in 12 patients with moderate to ...

Awakn Life Sciences Corp. (CSE: AWKN) (OTC Pink: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology ...

We are a drug and alcohol treatment center accredited ... clients through residential and/or outpatient treatment, relapse prevention, and aftercare. Each client receives a personalized treatment ...

I am a Certified Clinical Interventionist, an Advanced Certified Relapse Prevention Specialist and ... I am an Internationally Certified Drug and Alcohol Counselor, with over three decades of ...

Atai Life Sciences N.V. reported positive top-line phase 2a results of BPL-003 in treating Alcohol Use Disorder patients.